The following Studies are available for registration. Choose your study, click on it and follow the process. DALLAS STUDIES: Study #C10-D084: CALLUS CUSHION Start Date: Mar 24 2010 7:30AM End Date: Apr 8 2010 10:00AM Study Description: This study involves 3 Consecutive Clinic Visits During a 1-Week Timeframe. Compensation up to $50.00 (checks to be mailed upon completion of study) GROUP 1: 03/24/10 - 03/26/10 GROUP 2: 03/29/10 - 03/31/10 GROUP 3: 04/08/10 - 04/08/10 Study Objective: This study is being conducted to compare the adherence properties of a callus remover cushion product when used over a wear period of 48 hours. Eligibility: Subjects must be generally healthy males and females age 18 or older. Subjects must be willing to wear the same pair of either dress, work or casual shoes for the 48 hour test period (no athletic shoes will be allowed). Subjects must be willing to bring shoes that have a heel height of ¡Ü1.5 inches and that do not have open shoe areas (e.g., toe, heel or sides)to visit 1. Must be able to read and understand English. 6. Subjects must be willing to wear the assigned cushions for a minimum of 48 hours. Ages: 18 years or older >> View the Study Calendar and Requirements Study #C10-D086: LOOSE POWDER Start Date: Mar 23 2010 3:30PM End Date: May 5 2010 6:30PM Study Description: This Study Involves 3 Clinic Visits over a 6-Week Period. Compensation up to $90.00 GROUP 1: 03/23/10 - 05/04/10 GROUP 2: 03/24/10 - 05/05/10 Study Objective: This clinical study is being conducted in order to determine the safety, acnegenicity and comedogenicity testing of a loose powder. Eligibility: Females age 18-45 years old in general good health. Subjects will have self perceived acne-prone facial skin and/or sensitive skin. Must be able to read & understand English. Ages: 18-45 >> View the Study Calendar and Requirements Study #C10-D058: SPF LOTION Start Date: Mar 22 2010 10:00AM End Date: May 21 2010 1:00PM Study Description: This study involves 4 Clinic Visits over an 8-Week period. Compensation up to $130.00 GROUP 2: 03/22/10 - 05/17/10 GROUP 3: 03/25/10 - 05/20/10 GROUP 4: 03/26/10 - 05/21/10 Study Objective: This clinical study is being conducted in order to evaluate the effectiveness and tolerability of a SPF lotion alone and SPF lotion combined with night cream on female subjects with mild to moderate lines and wrinkles in the periocular area, wrinkles on the forehead area, and nasolabial fold. Eligibility: Females, ages 40 to 65 years of age, inclusive, who are in general good health. Clinically determined mild to moderate fine lines and wrinkles. Potential subjects will be instructed to discontinue the use of facial moisturizers at least 48-72 hours prior to the baseline visit. Must be able to read and understand English. Ages: 40-65 >> View the Study Calendar and Requirements Study #C10-D076: PHOTOAGING Start Date: Mar 19 2010 3:30PM End Date: May 18 2010 6:30PM Study Description: This study involves 4 Clinic Visits over an 8-Week period. Compensation up $130.00 GROUP 2: 03/19/10 - 05/13/10 GROUP 3: 03/23/10 - 05/18/10 Study Objective: This clinical study is being conducted in order to evaluate the effectiveness and tolerability of a hand and body cream on female subjects with moderate photdamaged skin on the hands, neck and chest areas. Eligibility: Females, ages 35-60 years of age, who are in general good health. Clinically determined moderate photodamaged skin on the backs of hands, neck and decolletage. Must be able to read and understand English. Ages: 35-60 >> View the Study Calendar and Requirements Study #C10-D057: FACIAL LOTION Start Date: Feb 25 2010 3:30PM End Date: Apr 27 2010 6:30PM Study Description: This Study Is A Facial Lotion Usage Study Requiring 4 Clinic Visits Over An 8 Week Timeframe. Compensation Up To $130.00 Study Objective: This Clinical Study Is Being Conducted In Order To Evaluate The Effectiveness And Tolerability Of A Face Lotion On Female Subjects. Eligibility: Females In General Good Health, Must Be Able To Read & Understand English. Ages: 40 - 65 Years Of Age >> View the Study Calendar and Requirements Study #C09-D304: ACNE Start Date: Feb 4 2010 3:30PM End Date: Jun 17 2010 6:30PM Study Description: This Study Requires 7 Clinic Visits Over a 12-Week Period. Compensation Up To $300.00 Group 2: 02/04/10-04/29/10 Group 3: 02/23/10-05/18/10 Group 4: 03/09/10-06/01/10 Group 5: 03/15/10-06/07/10 Group 6: 03/25/10-06/17/10 Study Objective: The primary objective is to evaluate the safety, tolerance and efficacy of topical acne treatments. Eligibility: (Screening) Potential subjects will report to the clinic (having removed all facial makeup at least 1 hour prior to their schedule appt) to have their faces examined for the presence of moderate to severe acne. Subjects will need to have between 20 and 50 inflammatory (red, raised) acne lesions, and between 30 and 100 non-inflammatory lesions. Qualified subjects will complete normal paperwork, females (of child bearing potential) will take a pregnancy test. Ages: Male & Females ages 12-45 >> View the Study Calendar and Requirements COLORADO SPRINGS STUDIES: Study #C11-C247: Hidradenitis Suppurativa (HS) Start Date: Feb 15 2012 8:00AM End Date: Dec 12 2012 11:00AM Study Description: This study will last about 50 weeks Compensation: Up to $72 per completed study visit Scheduling Window: Wednesdays, 8-11:00am (Must be scheduled by an S&A representative ) Study Objective: The primary objective of this clinical research study is to evaluate the safety (tolerance) and effectiveness of the investigational drug adalimumab in subjects with moderate to severe hidradenitis suppurativa (HS). Eligibility: Adult males and females, with a diagnosis of hidradenitis suppurativa (HS) for at least 1 year, a stable HS for at least 2 months prior to the study start in at least two distinct areas of the body. Ages: 18 and older >> View the Study Calendar and Requirements Study #C12-C059: Lip Product Usage Start Date: Feb 7 2012 8:00AM End Date: Mar 9 2012 10:00AM Study Description: Efficacy groups will require 4 visits over approximately 4 weeks. QUestionnaire only group will require 2 visits over approximately 2 weeks. Visit times are 8-10:00am. Compensation up to $100 for efficacy groups, $50 for questionnaires only. Study Objective: The objective of this 4-week clinical study is to assess the efficacy and tolerability of the Sponsor’s lip products to moisturize the lips, and improve lip condition in individuals with mild-to-moderate dry, chapped lips as evaluated by clinical grading and self-assessment questionnaires. A separate 1-week research guidance test (RGT) is being conducted to provide additional data for subjects’ perceptions of the test materials using self-assessment questionnaires. All RGT panelists must have self-perceived dry lips, to be eligible. Eligibility: Eligible subjects are females 35-55 years of age (efficacy group must clinically qualify with mild to moderate dry lips, due to dryness). Questionnaire portion, subjects MUST have self-perceived dry lips. Must be a REGULAR user (at least 5 days a week) of lip products (clear or colored). CANNOT be participating in any other usage studies and cannot participate in a face study simultaneously. Must have a 30-day rest period from any previous lip study or study where a test product was applied to lips. Must be willing to comply with at least a 2- day washout period (no products such as lip balms, lipstick, chapstick, lotions, treatments, etc. applied to the lips) prior to visit 1. Must be willing to remove the test product with their regularly used cleanser or makeup remover a minimum of 20 minutes prior to each post visit, after visit 1. Must be willing to follow study guidelines. Ages: 35-55 >> View the Study Calendar and Requirements Study #C11-C296: Dry skin 65 and older Start Date: Feb 6 2012 1:00PM End Date: Apr 12 2012 5:00PM Study Description: Prior to visit 1 all prospective subjects will fulfill a three day washout NOT using any moisturizing products on the face and legs. Panelists will undergo clinical grading to determine enrollment in the study. Qualified subjects will undergo clinical assessments/procedures, to include photos and receive the test products to be used at home for the duration of the study. Subjects will return for subsequent visits to repeat clinical procedures, performed at visit 1, as well as tape stripping (final visit). The lower legs and full face (split face) randomized by right side and left side, will be used as the test areas. Compensation: Up to $175.00 Scheduling Window: 1:00-5:00pm Must be scheduled by an S&A recruiter Study Objective: The primary objective of this clinical research study is to evaluate the effect of a topical product at two concentrations on dry skin for 8 weeks on the lower legs and the face Eligibility: Females, between the ages of 18-45 with normal skin on the legs and face AND females, 65 and older with moderate to severe dry skin on the lower legs and face. Qualified subjects will have very light to very dark olive skin color. All panelist information held in strict confidence. All interested panelists may be contacted via telephone. Panelist information may be added to a centralized database Ages: 65 and older >> View the Study Calendar and Requirements Study #C12-C016: Itch Device Start Date: Feb 1 2012 8:00AM End Date: Mar 15 2012 12:30PM Study Description: Prior to visit 1 all prospective subjects will have completed a two day (or in the 48 hours preceding”) not using any topical steroids in the test area and NOT using any moisturizers on the day of the study visit. At visit 1 prospective subjects will be screened to confirm the diagnosis of atopic dermatitis/eczema by a board certified dermatologist. Qualified subjects will complete paperwork, have photos taken of the skin area, complete itch intensity questionnaires and have the device applied to the skin (in clinic) for 25 minutes of use. Subjects will return for visit 2 to repeat clinical procedures, as described above. You will return the following day after each visit to return questionnaires. Compensation: Up to $120.00 Scheduling Window: To be entered as finalized Must be scheduled by an S&A recruiter Study Objective: The primary objective of this 1-week (4-visit) clinical research study is to evaluate the safety (tolerance) and efficacy of a device applied once compared with another device on reduction of itch associated with atopic dermatitis (eczema) within 9 hours after treatment. Eczema is often associated with red, itchy, scaly patches of skin Eligibility: Males and females, at least 18 years of age with active eczema/atopic dermatitis lesions, involving localized areas of skin, involving <20% body surface area and active itch. Ages: 18 and older >> View the Study Calendar and Requirements Study #C12-C020: Eczema Body Wash Start Date: Jan 5 2012 5:00PM End Date: Mar 12 2012 7:30PM Study Description: Prior to visit 1 all prospective subjects will have not showered/bathed within 3 hours of the study visit. At visit 1 prospective subjects will be screened for the diagnosis of 2 active eczema lesions by a board certified dermatologist. Qualified subjects will have photos taken of the affected sites and surrounding area, undergo instrumental assessments, measurements and receive a bottle of standard liquid wash for use at home for all general body cleansing needs. Subjects will return for visit 2 to repeat clinical grading, photos, instrumental measurements and to receive the test article. Subjects will return for subsequent visits to undergo clinical procedures, as described above and to complete a questionnaire on skin condition. Must have a minimum 4 week rest period from ANY previous clinical study. Must agree to refrain from showering/bathing within 3 hours before each scheduled study visit. Must have 2 active eczema lesion (redness, itchy, scaly patches of skin) (preferably on the arms and/or legs) to be considered for study participation. Must be willing to avoid use of any moisturizer use over the entire body (unless ongoing moisturizer use has been prescribed by a physician) for the duration of the study. Cannot be a current user of new prescriptions for a skin condition (within 3 months) of the study start. Compensation: Up to $150.00 Study Objective: The objective of this clinical research usage study is to evaluate the compatibility of a cosmetic liquid cleanser (body wash) and clinical benefits in a non-diseased area of the skin in children and adult subjects with clinically diagnosed mild to moderate eczema. Eczema is often associated with red, itchy, scaly patches of skin. Eligibility: Male and female, adult subjects within the ages of 18-65 and children between the ages of 5-14, with at least 2 active eczema lesions (preferably on the arms and/or legs) who have not participated in a clinical research study within 4 weeks prior to the study start. All panelist information held in strict confidence. All interested panelists may be contacted via telephone. Panelist information may be added to a centralized database Ages: 5-14 and 18-65 >> View the Study Calendar and Requirements Study #C11-C256: Psoriasis Start Date: Dec 7 2011 8:00AM End Date: May 15 2013 12:00PM Study Description: At visit 1, all prospective subjects will be screened for the presence of chronic moderate to severe plaque-type psoriasis. Qualified subjects will receive a study drug and/or placebo, to be used at home. At week 12 of the study, a maintenance period up to week 52 will be followed. Subjects will be followed through the maintenance period, every four weeks. A follow-up period (after 52 weeks up to week 60) will include additional clinic visits. Compensation: Up to $900.00 Scheduling Window: Wednesdays 8:00am-12:00pm (Must be scheduled by an S&A recruiter) Study Objective: The purpose of this clinical research study is to determine the safety (tolerance), tolerability and long-term efficacy up to one year of an investigational medication in subjects with moderate to serve chronic plaque-type psoriasis Eligibility: Males and females, ages 18 and older, with chronic plaque-type moderate to severe plaque psoriasis, diagnosed for at least 6 months prior to the study start and are poorly controlled by topical treatments and/or phototherapy and/or previous systemic therapy. Ages: 18 and older >> View the Study Calendar and Requirements